Agenus swings to Q2 FY26 net loss of $0.6 million; revenue rises 34.24% to $34.5 million year-over-year

Reuters2026/08/06 11:35

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Agenus posted Q2 revenue of $34.5 million, up 34.24% from $25.7 million a year earlier.
Operating income was $11.3 million, swinging from an operating loss of $16.7 million in Q2 2025.
Net income was a loss of $0.6 million, improving from a net loss of $30 million a year earlier.
Cash and cash equivalents ended Q2 at $18.7 million; a July private placement added about $85 million in gross cash proceeds.
Management said the financing supports the planned Phase 3 ROBBIN trial of BOT+BAL, with first patient dosing expected in Q1 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agenus Inc. published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Agenus swings to Q2 FY26 net loss of $0.6 million; revenue rises 34.24% to $34.5 million year-over-year

You may also like

Crypto prices